Optimal INR level in patients with atrial fibrillation with EHRA type 2 valvular heart disease receiving warfarin
Abstract Background To date, there has been no study that compares the efficacy and safety of warfarin in atrial fibrillation (AF) patients with Evaluated Heartvalves, Rheumatic or Artificial (EHRA) type 2 valvular heart disease (VHD). This study was conducted to determine the optimal INR in these p...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-06-01
|
Series: | Journal of Arrhythmia |
Subjects: | |
Online Access: | https://doi.org/10.1002/joa3.12342 |